TROY, Mich., Nov. 8 /PRNewswire/ -- Delphi Medical Systems, a subsidiary of Delphi Corp., plans to showcase its products and services at the 2005 Medica Trade Show next week in Duesseldorf, Germany, November 16-19.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050222/DETU002LOGO )
Medica is the world's largest annual medical trade show. Visitors to booth A 23-4, Hall 14, at this year's Medica show will have the opportunity to learn more about Delphi Medical Systems' operations, product portfolio, and plans to serve customers in Europe.
In addition to introducing visitors from around the world to Delphi Medical Systems, visitors can see the following products:
* Delphi IVantage pump, a portable infusion system, distributed by with Fresenius-Kabi.
* PocketChart(TM), Electronic Medical Records (EMR) software system that allows doctors to track their patients. Currently the version for sale is in English and based on U.S. Healthcare codes. Several European versions including one for Germany, France and the U.K. are currently in development, for release in 2006.
* VitalPoint(TM) Home, a compact vital signs monitor that allows a patient mobility while allowing them to send their medical information to their doctor or caregiver remotely.
* VitalPoint(TM), a point-of-care physician's version of the 1.5 kg patient monitor.
"We believe that these products and our services can help doctors, nurses, caregivers and patients around the world," said Christophe Sevrain, managing director, Delphi Medical Systems (DMS). "Between helping patients at home, which is a growing need around the world, to helping doctors keep electronic records on their patients, helping to ensure constantly monitored healthcare, Delphi Medical offers many options and solutions in the healthcare industry."
Learn more about Delphi Medical Systems' products and services at booth A 23-4, Hall 14 at the Duesseldorf Exhibition Center at Medica from November 16- 19.
For more information about Delphi Medical Systems, visit http://www.delphimedical.com . For more information on Delphi and its subsidiaries, visit http://www.delphi.com/media .
Forward-Looking Statement
This press release as well as other statements made by Delphi may contain forward-looking statements within the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that reflect, when made, the Company's current views with respect to current events and financial performance. Such forward looking statements are and will be, as the case may be, subject to many risks, uncertainties and factors relating to the Company's operations and business environment which may cause the actual results of the Company to be materially different from any future results, express or implied, by such forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following: the ability of the Company to continue as a going concern; the ability of the Company to operate pursuant to the terms of the DIP facility; the Company's ability to obtain court approval with respect to motions in the chapter 11 proceeding prosecuted by it from time to time; the ability of the Company to develop, prosecute, confirm and consummate one or more plans of reorganization with respect to the chapter 11 cases; risks associated with third parties seeking and obtaining court approval to terminate or shorten the exclusivity period for the Company to propose and confirm one or more plans of reorganization, for the appointment of a chapter 11 trustee or to convert the cases to chapter 7 cases; the ability of the Company to obtain and maintain normal terms with vendors and service providers; the Company's ability to maintain contracts that are critical to its operations; the potential adverse impact of the chapter 11 cases on the Company's liquidity or results of operations; the ability of the Company to fund and execute its business plan; the ability of the Company to attract, motivate and/or retain key executives and associates; and the ability of the Company to attract and retain customers. Other risk factors are listed from time to time in the Company's SEC reports, including, but not limited to the annual report on Form 10-K for the year ended December 31, 2004 and its most recent quarterly report on Form 10-Q and current reports on Form 8-K. Delphi disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Similarly, these and other factors, including the terms of any reorganization plan ultimately confirmed, can affect the value of the Company's various pre-petition liabilities, common stock and/or other equity securities. No assurance can be given as to what values, if any, will be ascribed in the bankruptcy proceedings to each of these constituencies. Accordingly, the Company urges that the appropriate caution be exercised with respect to existing and future investments in any of these liabilities and/or securities.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050222/DETU002LOGOPRN Photo Desk photodesk@prnewswire.comDelphi Medical SystemsCONTACT: Mary McCahon of Delphi Medical Systems, +1-248-813-2618,mary.mccahon@delphi.com
Company News On-Call: http://www.prnewswire.com/comp/076666.html/
